CIC
ARNA

Chase Investment Counsel’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Chase Investment Counsel’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,050
Closed -$20K – 107
2016
Q1 		$20K Hold
1,050
– – 0.01% 99
2015
Q4 		$19K Buy
+1,050
New +$21.4K 0.01% 88

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Chase Investment Counsel's ARNA Position: Q2 2016 in Review

Chase Investment Counsel sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2016, closing a stake of 1,050 shares — an estimated $20K sold.

Chase Investment Counsel first reported a position in ARNA in Q4 2015 and held it in 2 quarters. The position peaked at $20K in Q1 2016. 119 funds tracked by Wall St. Rank hold ARNA as of Q2 2016.

  • Chase Investment Counsel reported no remaining Arena Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Chase Investment Counsel sold 1,050 Arena Pharmaceuticals Inc shares in Q2 2016, an estimated $20K.
  • Chase Investment Counsel first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 2 quarters.
  • Chase Investment Counsel's Arena Pharmaceuticals Inc position peaked at $20K in Q1 2016.
  • 119 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2016.

Based on Chase Investment Counsel's 13F filing for Q2 2016, filed 27 Jul 2016.